The bispecific antibody cG7-MICA targets both the natural killer (NK) cell receptor NK group 2, member D (NKG2D) ligand MHC class I-related chain A (MICA), and CD24, which reduces tumor volume and improves survival rates in Huh-7-bearing nude mice [76]. The gene discussed is MICA; the disease is neoplasm.